Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

2.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.1K
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

116
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
116
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.0K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

363
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
363
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.1K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.1K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.7K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Cross-kingdom interactions in oral dysbiosis and host response.

Frontiers in dental medicine·2025
Same author

Non-linear plasma protein binding of cannabidiol.

Journal of cannabis research·2024
Same author

Cannabis Pharmacogenomics: A Path to Personalized Medicine.

Current issues in molecular biology·2023
Same author

Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations.

Pathogens (Basel, Switzerland)·2022
Same author

COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics.

Methods in molecular biology (Clifton, N.J.)·2022
Same author

Autism and associated disorders: cannabis as a potential therapy.

Frontiers in bioscience (Elite edition)·2022

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.4K

Pharmacogenomics Informs Cardiovascular Pharmacotherapy.

Mariana Babayeva1, Brigitte Azzi1, Zvi G Loewy2,3

  • 1Touro College of Pharmacy, New York, NY, USA.

Methods in Molecular Biology (Clifton, N.J.)
|September 6, 2022
PubMed
Summary
This summary is machine-generated.

Precision medicine uses genetic information to tailor treatments, improving cardiovascular pharmacotherapy. Understanding genetic variations helps predict patient response and reduce side effects for better clinical decisions.

Keywords:
GenotypePersonalized medicinePolymorphism

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.5K

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
08:21

Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations

Published on: July 21, 2023

1.4K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.8K
Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

1.5K

Area of Science:

  • Pharmacogenomics
  • Cardiovascular Medicine
  • Personalized Medicine

Background:

  • Precision medicine offers tailored treatments based on individual genetic makeup.
  • Pharmacogenomics is crucial for understanding how genetic variations affect drug response.
  • Personalized pharmacotherapy can enhance clinical decision-making.

Purpose of the Study:

  • To highlight the role of pharmacogenomics in cardiovascular pharmacotherapy.
  • To explain how genetic variations influence drug efficacy and safety.
  • To underscore the benefits of personalized treatment approaches in cardiology.

Main Methods:

  • Review of current literature on pharmacogenomics in cardiovascular medicine.
  • Analysis of genetic variations impacting drug metabolism and targets.
  • Integration of genetic data into clinical decision support tools.

Main Results:

  • Genetic variations significantly alter patient responses to cardiovascular drugs.
  • Pharmacogenomic insights can optimize drug selection and dosage.
  • Predicting adverse drug reactions based on genetic profiles is feasible.

Conclusions:

  • Pharmacogenomics is essential for advancing personalized cardiovascular care.
  • Integrating genetic information improves treatment outcomes and patient safety.
  • Further research is needed to fully implement pharmacogenomic strategies in cardiology.